Vanda Pharmaceuticals
VNDA
VNDA
101 hedge funds and large institutions have $428M invested in Vanda Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
101
Holding in Top 10
1
Calls
$10.5M
Puts
$13.7M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$9.02M | |
| 3 | +$7.03M | |
| 4 |
Millennium Management
New York
|
+$3.73M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.7M |
Top Sellers
| 1 | -$7.36M | |
| 2 | -$2.01M | |
| 3 | -$1.32M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.23M |
| 5 |
SCA
Signpost Capital Advisors
New York
|
-$1.19M |